Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Versant Ventures
Biotech
Versant unveils Pep2Tango, a biotech with next-gen obesity hopes
Versant has unveiled Pep2Tango, a biotech developing next-gen obesity therapeutics with multiple targets to overcome GLP-1 limitations.
Gabrielle Masson
Nov 21, 2024 11:11am
Novartis, Versant hope to repeat Chinook’s success with Borealis
Aug 22, 2024 8:00am
J&J, Bayer, Santa Ana, Regenxbio and more—Chutes & Ladders
Jun 14, 2024 8:30am
Ex-Kite leader helms Santa Ana’s ship with $168M in hand
Jun 13, 2024 8:00am
AstraZeneca to climb weight loss mountain with $80M for SixPeaks
May 22, 2024 10:00am
Firefly Bio assembles with $94M and an ADC dream team
Feb 15, 2024 8:11am
